IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1492 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission


This article has been cited by
1Active Monitoring of Adverse Drug Reactions with Neural Network Technology
Tao Wu,Chang-Chun Gao,Jing-Sheng Lin,Jia-Ling Zha
Chinese Medical Journal.2017;130(12)1498
2Advances in pharmacovigilance in India: Role of mobile application
Rajpushpa Labh,Sachin Gupta,Rachna Gupta
Indian Journal of Medical Specialities.2020;0(0)0
3A national approach to pharmacovigilance: The case of India as a growing hub of global clinical trials
Swapnil Dylan Fernandes,Narayanan V. Anoop,Lovely Joylen Castelino,R. Narayana Charyulu
Research in Social and Administrative Pharmacy.2019;15(1)109
4Global Versus Indian Perspective of Pioglitazone-induced Adverse Drug Reactions Including Bladder Cancer: A Comparative Retrospective Pharmacovigilance Analysis
Shashi Bhushan,R.S. Ray,Jai Prakash,G.N. Singh
Clinical Therapeutics.2019;41(11)2252
5Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati
Rajalakshmi Rukmangathen,VasundaraDevi Brahmanapalli,DurgaPrasad Thammisetty,Deepishka Pemmasani,SaiDeepak Gali,RameshBabu Atmakuru
Perspectives in Clinical Research.2019;0(0)0
6Audit to evaluate the completeness of adverse drug reporting in an ADR monitoring centre in Tamilnadu
Shanmugapriya S.,Bhuvaneswari K.,Karthika P.
Indian Journal of Medical Specialities.2017;8(4)175
7Decoding the Roadmap for Capacity Building of Pharmacology Academicians in Catering to Drug Information Center Services in a Developing Country
Praveen Kumar M,Amol Patil,Ashish Kumar Kakkar,Harmanjit Singh
Journal of Pharmacy Technology.2019;35(4)146
8Vaccine pharmacovigilance in India: Current context and future perspective
BikashRanjan Meher
Indian Journal of Pharmacology.2019;51(4)243
9Vaccine pharmacovigilance in India: Current context and future perspective
Avinash Arivazhahan,Sushil Kiran Kunder
Indian Journal of Pharmacology.2019;51(4)177
10Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions
Rubina Mulchandani,Ashish Kumar Kakkar
International Journal of Risk & Safety in Medicine.2018;30(1)33
11Emerging antimicrobial resistance and newer tools to address the resistance
PardeepKumar Goyal,Ankita Semwal,Ajay Prakash,Bikash Medhi
Indian Journal of Pharmacology.2019;51(5)291
12Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria
Abimbola O. Opadeyi,Annie Fourrier-Réglat,Ambrose O. Isah
Therapeutic Advances in Drug Safety.2019;10(5)204209861881627
13Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital
Meda Venkatasubbaiah,P. Dwarakanadha Reddy,Suggala V. Satyanarayana
Alexandria Journal of Medicine.2018;54(4)597
14An observational study to assess the possibility of patient participation in implementing pharmacovigilance in a busy tertiary care hospital
A. Tejus,A.G. Mathur,R. Vishnuprasad,Akansha Singh,Sapna Pradhan
Medical Journal Armed Forces India.2019;54(4)597
15‘Have we missed reporting adverse drug reactions under Revised National TB Control Programme?’ - A mixed method study in Bengaluru, India
Lalitha Krishnappa,Suman Gadicherla,Priyadarshini Chidambaram,H.V. Anuradha,Shivaraj Nallur Somanna,Poonam Ramesh Naik,Arundhati Das,Somashekar Narasimhaiah,Sharath Burugina Nagaraja
Indian Journal of Tuberculosis.2020;67(1)20
16Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives
Jobin Jose,Naziya Refi Rafeek
Therapeutic Innovation & Regulatory Science.2019;53(6)781
17Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
Abimbola O. Opadeyi,Annie Fourrier-Réglat,Ambrose O. Isah
BMC Pharmacology and Toxicology.2018;19(1)781
18Pharmacovigilance in India: Present Scenario and Future Challenges
V. Kalaiselvan,Sushma Srivastava,Abhishank Singh,SK Gupta
Drug Safety.2019;42(3)339
19Pharmacovigilance Program of India
Urmila M. Thatte,Nayan L. Chaudhari,Nithya J. Gogtay
Adverse Drug Reaction Bulletin.2018;312(1)1207
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow